Michael J Olszewski

6505--Prednisolone 1% Ophthalmic Solution

The Department of Veterans Affairs, through the OPAL Enterprise Procurement Office, is soliciting offers for the procurement of Prednisolone Acetate 1% Ophthalmic Suspension. This unrestricted procurement is designated as a HUBZONE Small Business set-aside and aims to establish an uninterrupted source of supply for the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers. The contract consists of a one-year base period with four pre-priced one-year option periods. Supplies will be distributed via the VA and DoD Pharmaceutical Prime Vendor Programs, with requirements for three package sizes: 5ml, 10ml, and 15ml bottles. Award will be made to a single responsible offeror for all line items based on the Lowest Price Technically Acceptable (LPTA) approach. To be considered technically acceptable, offerors must provide FDA-approved pharmaceuticals with unique 11-digit NDC numbers and demonstrate that manufacturing facilities are FDA cGMP acceptable. Strict packaging and labeling standards are required, including GS1-128 or HIBC linear bar codes and 2D data matrix bar codes per the Drug Supply Chain Security Act. Proposals must be submitted by October 14, 2026, and must include a signed SF-1449, a 0.5% cost recovery fee in the pricing, and a letter of commitment from the manufacturer if the offeror is not the producer.

Department Of Veterans AffairsIL,

NAICS

325412

Pharmaceutical Preparation Manufacturing

PSC

6505

Medical, Dental, and Veterinary Equipment and Supplies

Posted Sep 30, 2026

36E79726R0037

Closed

Awarded3

6505--Ropinirole HCL Tablets 9/28/2026 - 9/27/2027

The contract is a requirements-based procurement by the Department of Veterans Affairs for the supply of generic Ropinirole HCL tablets in multiple strengths, covering a base year from September 28, 2026, through September 27, 2027, with four additional one-year option periods that may be unilaterally exercised by the government, for a potential total duration of five years. The procurement is structured as a Firm Fixed Price Indefinite-Delivery Requirements contract administered through Prime Vendors including McKesson, Cardinal Health, and Cencora, with deliveries made to these vendors’ distribution centers rather than directly to VA facilities. All products must comply with FDA regulations, current Good Manufacturing Practices, and United States Pharmacopeia standards, and are subject to strict packaging requirements: non-glass containers, child-resistant caps for smaller quantities, compatibility with automated dispensing systems, and full compliance with Drug Supply Chain Security Act mandates including the use of two-dimensional GS1 Data Matrix barcodes at the lowest saleable level. Each drug tablet must bear an 11-digit NDC number, with barcodes printed in GS1-128, HIBCC, or UPC format at ANSI/ISO/IEC Quality Grade C or higher, accompanied by human-readable NDC numbers for BCMA system compatibility. The award will be made on a Lowest Priced Technically Acceptable basis, where technical acceptability—including compliance with labeling, barcoding, stability testing, facility disclosures, and regulatory registrations—is the threshold requirement, and price determines selection among qualified offers. Contractors must submit a small business subcontracting plan if applicable, disclose all packaging and repackaging locations, register NDCs with FDA and commercial databases within five days of award, and immediately notify the contracting officer of any backorders. Offerors must have a valid Unique Entity Identifier, provide complete pricing for all line items across the base and option years, and adhere to submission requirements that restrict proposals to PDF or Microsoft Word formats via email, with no faxed or zipped submissions allowed. The contracting officer, Michael Olszewski, is the point of contact located in Hines, Illinois.

Department Of Veterans AffairsIL, USA

NAICS

325412

Pharmaceutical Preparation Manufacturing

PSC

6505

Medical, Dental, and Veterinary Equipment and Supplies

unrestricted

Awarded

Awarded3

6505--Naproxen Tablets 8-1-2026 - 7-31-2027

The Department of Veterans Affairs National Acquisition Center plans to issue a Request for Proposal (RFP 36E79726R0011) for the procurement of Naproxen Tablets to serve the VA, Department of Defense, Bureau of Prisons, and Indian Health Service. This contract aims to establish a one-year base period with four additional one-year option periods to ensure a continuous supply of Naproxen tablets. The contract will involve distribution through the VA Pharmaceutical Prime Vendor Programs. Offerors are required to provide the exact drug name as it appears on the label and must supply products with unique NDC or UPC codes. The solicitation will be issued electronically in commercial item format around February 10, 2026, with responses due by February 24, 2026. All solicitation materials and amendments will be available solely through the government procurement website, and interested vendors must monitor it for updates. The estimated annual quantities for the contract include various strengths and bottle sizes of Naproxen tablets, ranging from 250 mg to 500 mg, in 100-tablet and 500-tablet bottles. The largest volume is for the 500 mg tablets in 500-count bottles, with an estimated annual requirement exceeding 115,000 bottles. The North American Industry Classification System (NAICS) code for this procurement is 325412, identifying the pharmaceutical manufacturing sector. The contracting point of contact is Michael Olszewski, who can be reached via email for questions related to the solicitation. This procurement seeks responsible sources capable of providing an uninterrupted supply to meet the comprehensive pharmaceutical needs of several federal health entities.

Department Of Veterans AffairsIL, USA$13M est.

NAICS

325412

Pharmaceutical Preparation Manufacturing

PSC

6505

Medical, Dental, and Veterinary Equipment and Supplies

36E79726R0011

Awarded

Awarded1

6505--Venlafaxine Tablets

The Department of Veterans Affairs, through the National Acquisition Center, awarded contract 36E79726D0015 to Golden State Medical Supply, Inc. for the procurement of Venlafaxine Tablets. The contract, stemming from solicitation 36E79725R0054, was awarded on January 16, 2026, for a total value of $4,064,495.77. The procurement falls under NAICS code 325412 for Pharmaceutical Preparation Manufacturing and Product Service Code 6505. The primary deliverable is the supply of Venlafaxine Tablets under line item 5. While specific delivery schedules, quantities, and technical specifications are not detailed in the award notice, the contractor is based in Camarillo, California, and the contracting office is located in Hines, Illinois. Michael Olszewski serves as the primary point of contact for the contract. No specific set-aside categories or special contract requirements were identified in the available documentation.

Department Of Veterans AffairsIL, USA$4.1M est.

NAICS

325412

Pharmaceutical Preparation Manufacturing

PSC

6505

Medical, Dental, and Veterinary Equipment and Supplies

36E79725R0054

Awarded

Awarded3

6505--Alendronate Tablets Effective 05/21/2026 - 05/20/2027

This contract pertains to the procurement of Alendronate Tablets for the Department of Veterans Affairs, managed through the Nac Pharmaceuticals solicitation number 36E79725R0069. The acquisition involves a one-year base period with four optional one-year extensions, aiming to supply specified quantities of 35MG and 70MG tablets in various packaging configurations, including bottles and blister packs, with detailed packaging, labeling, and bar-coding requirements aligned with federal standards. The solicitation emphasizes compliance with FAR clauses, including those related to security, privacy, small business subcontracting, and anti-conflict provisions, with references to the USP-NF for pharmaceutical standards and federal specifications for packaging and labeling. Offerors are required to submit firm-fixed-price proposals, including a 0.5% Cost Recovery Fee, covering all line items across the base and option years, with evaluation based on lowest evaluated price among technically acceptable and responsible offers. The contract mandates strict delivery and inspection protocols, with products inspected and accepted at the Government’s destination, ensuring all pharmaceuticals are FDA-approved and manufactured under current Good Manufacturing Practices. Delivery is structured through the Prime Vendor system, with performance periods defined by an implementation window of up to 60 days post-award and subsequent ordering periods extending up to five years, including options. Proposal submissions must be made electronically via email, including a signed SF-1449, with no page limits specified, and must be received by the deadline of November 13, 2025. The contract incorporates extensive FAR and VAAR clauses covering ethics, security, subcontracting, and reporting requirements, and emphasizes the importance of accurate representations regarding small business status, socioeconomic categories, and compliance certifications. Overall, the contract emphasizes quality, compliance, and cost-effectiveness in supplying pharmaceuticals to support VA healthcare operations.

Department Of Veterans AffairsIL, USA$4.4M est.

NAICS

325412

Pharmaceutical Preparation Manufacturing

PSC

6505

Medical, Dental, and Veterinary Equipment and Supplies

36E79725R0069

Awarded

Awarded1

6505--Nicotine 24hrs Patches

The contract titled "6505--Nicotine 24HRS Patches" is issued by the Department of Veterans Affairs through the Nac Pharmaceuticals organization, located in Hines, Illinois. It is associated with NAICS code 325412, which pertains to pharmaceutical and medicine manufacturing. The solicitation was posted on October 14, 2025, and involves the procurement of nicotine patches designed to be effective for 24 hours. The contract appears to be a government procurement effort aimed at providing nicotine replacement therapy products, likely to support veterans' health and wellness programs. The primary point of contact for this contract is Michael Olszewski, reachable via email at [email hidden] or by phone at [phone hidden]. Further details about the contract, including specific requirements and scope, can be accessed through the provided link on SAM.gov. The contract does not specify a particular dollar value or set-aside status, indicating it may be open or under consideration for various vendors.

Department Of Veterans AffairsIL,

NAICS

325412

Pharmaceutical Preparation Manufacturing

PSC

6505

Medical, Dental, and Veterinary Equipment and Supplies

36E79725R0050

Awarded Aug 7, 2025

Awarded1

6505--Losartan Tablets

The contract pertains to the procurement of Losartan Tablets under solicitation number 36E79725R0032, posted on May 8, 2025, with a response deadline of May 22, 2025. The project is managed by Nac Pharmaceuticals, an organization based in Hines, Illinois, and is associated with the NAICS code 325412, which relates to pharmaceutical manufacturing. The contract aims to supply Losartan Tablets, a medication typically used to treat high blood pressure and related conditions. The solicitation is open and does not specify set-aside categories, indicating it may be available to a broad range of suppliers. Interested parties can contact the designated Contract Specialist, Michael J Olszewski, via email for further details. Additional information and updates about the contract can be accessed through the provided link on SAM.gov.

Department Of Veterans AffairsIL, USA$37.9M est.

NAICS

325412

Pharmaceutical Preparation Manufacturing

PSC

6505

Medical, Dental, and Veterinary Equipment and Supplies

36E79725R0032

Awarded Jul 2, 2025

Federal1

6505--Fluticasone Propionate 50 MCG/Spray Soln, Nasal, 16GM

The Department of Veterans Affairs (VA), along with the Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS), plans to issue a solicitation for Fluticasone Propionate 50MCG/Spray solution, nasal, 16GM, to ensure an uninterrupted supply of this medication. The procurement will be awarded to a responsible offeror capable of providing consistent delivery through the VA's Pharmaceutical Prime Vendor Programs. The contract will span one year with four additional one-year options, allowing for extended supply if needed. The solicitation, identified as 36E79725R0017, is expected to be released electronically around February 11, 2025, with a deadline for responses set for February 25, 2025. Offerors must specify the exact drug name and have a unique NDC number to qualify. The estimated annual requirement for this medication is approximately 5,784,828 bottles, each containing 120 sprays, highlighting the significant demand across the participating agencies. The procurement falls under NAICS code 325412, which pertains to pharmaceutical manufacturing. Interested parties are instructed to monitor the designated website for updates, as no paper copies will be issued, and all questions should be directed to Michael Olszewski via email or phone. The contract aims to ensure a reliable supply of Fluticasone Propionate nasal spray to support the healthcare needs of veterans and other federal agencies involved.

Department Of Veterans AffairsIL,

NAICS

325412

Pharmaceutical Preparation Manufacturing

PSC

6505

Medical, Dental, and Veterinary Equipment and Supplies

Posted Feb 27, 2025

36E79725R0017

Closed

Awarded1

6505--Ketoconazole 0.02 Cream

The Department of Veterans Affairs, in collaboration with the Department of Defense, Bureau of Prisons, and Indian Health Service, plans to issue a Request for Proposal (RFP) for the procurement of Ketoconazole 2% Cream. This unrestrictive procurement aims to establish a reliable supply source for the specified medication, which will be distributed through the VA’s Pharmaceutical Prime Vendor Programs. The contract will span one year with four additional one-year options, ensuring continuity of supply. Offerors are required to specify the exact product name as it appears on the label and provide a unique NDC number for each item. The solicitation, designated as 36E79724R0032, will be released electronically around October 10, 2024, with a deadline for responses set for October 24, 2024. All related documents and updates will be available exclusively online at www.beta.sam.gov, with no paper copies issued or accepted. The estimated annual usage includes approximately 62,643 tubes of 15 grams, 233,385 tubes of 30 grams, and 139,890 tubes of 60 grams of Ketoconazole 2% Cream. The procurement falls under NAICS code 325412, indicating a pharmaceutical manufacturing focus. Interested responsible sources are encouraged to submit proposals, which will be evaluated for their ability to provide an uninterrupted supply. The primary point of contact is Michael Olszewski, who can be reached via email or phone for questions. The contract is managed by Nac Pharmaceuticals, located in Hines, Illinois, and all potential vendors are advised to monitor the specified website for any updates or amendments related to the solicitation.

Department Of Veterans AffairsIL, USA$11.9M est.

NAICS

325412

Pharmaceutical Preparation Manufacturing

PSC

6505

Medical, Dental, and Veterinary Equipment and Supplies

36E79724R0032

Awarded Feb 13, 2025

Federal1